Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12467390rdf:typepubmed:Citationlld:pubmed
pubmed-article:12467390lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0205103lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0002505lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0002482lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0598405lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0075804lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0061633lld:lifeskim
pubmed-article:12467390lifeskim:mentionsumls-concept:C0233656lld:lifeskim
pubmed-article:12467390pubmed:issue25lld:pubmed
pubmed-article:12467390pubmed:dateCreated2002-12-6lld:pubmed
pubmed-article:12467390pubmed:abstractTextNocathiacin I (1) and nocathiacin IV (2) are novel indole-containing thiazolyl peptide antibiotics, which exhibit potent activity against key Gram-positive bacterial pathogens, including multi drug-resistant Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecium. New nocathiacins 7-12 were prepared from 2 by a condensation with glycolaldehyde followed by tandem reductive amination of the 2-oxoethyl intermediate 4. The latter was formed via Amadori rearrangement from initial 2-hydroxyethylideneamide 3. This transformation readily tolerates the complex architecture of nocathiacins and allows selective incorporation of water solubilizing groups to the primary amide in 2 without protecting group manipulation.lld:pubmed
pubmed-article:12467390pubmed:languageenglld:pubmed
pubmed-article:12467390pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:citationSubsetIMlld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12467390pubmed:statusMEDLINElld:pubmed
pubmed-article:12467390pubmed:monthDeclld:pubmed
pubmed-article:12467390pubmed:issn0022-3263lld:pubmed
pubmed-article:12467390pubmed:authorpubmed-author:HuangStellaSlld:pubmed
pubmed-article:12467390pubmed:authorpubmed-author:LeetJohn EJElld:pubmed
pubmed-article:12467390pubmed:authorpubmed-author:UedaYasutsugu...lld:pubmed
pubmed-article:12467390pubmed:authorpubmed-author:HrnciarPeterPlld:pubmed
pubmed-article:12467390pubmed:authorpubmed-author:BronsonJoanne...lld:pubmed
pubmed-article:12467390pubmed:issnTypePrintlld:pubmed
pubmed-article:12467390pubmed:day13lld:pubmed
pubmed-article:12467390pubmed:volume67lld:pubmed
pubmed-article:12467390pubmed:ownerNLMlld:pubmed
pubmed-article:12467390pubmed:authorsCompleteYlld:pubmed
pubmed-article:12467390pubmed:pagination8789-93lld:pubmed
pubmed-article:12467390pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:meshHeadingpubmed-meshheading:12467390...lld:pubmed
pubmed-article:12467390pubmed:year2002lld:pubmed
pubmed-article:12467390pubmed:articleTitleSynthesis of novel nocathiacin-class antibiotics. Condensation of glycolaldehyde with primary amides and tandem reductive amination of amadori-rearranged 2-oxoethyl intermediates.lld:pubmed
pubmed-article:12467390pubmed:affiliationBristol-Myers Squibb Co., Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA.lld:pubmed
pubmed-article:12467390pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12467390lld:pubmed